D61.2

Clinical Causes: Exposure to certain chemicals: including benzene, solvents, and pesticides. Use of specific medications: such as chloramphenicol, certain antibiotics, and anticancer drugs. Environmental toxins: including exposure to radiation or toxic fumes. Chemotherapy treatments: administered for cancer that can damage the bone marrow. Heavy metal poisoning: such as arsenic or lead poisoning.

Key Symptoms: Fatigue and weakness: due to anemia from decreased red blood cells. Unusual bleeding or bruising: resulting from low platelet counts. Increased susceptibility to infections: caused by a reduced number of white blood cells. Pale skin and mucous membranes: reflective of anemia. Shortness of breath: especially during physical activity. Fainting episodes or dizziness: as a consequence of reduced oxygen delivery. High fever or chills: indicating possible infection.

Diagnosis Path: Diagnosis involves a comprehensive medical evaluation, blood tests, and bone marrow examination. Blood counts typically reveal pancytopenia (a deficiency of all blood cell types). A bone marrow biopsy is essential to assess marrow cellularity and to distinguish aplastic anemia caused by external agents from other marrow disorders. Additional tests may include assessing for exposure to specific toxins and reviewing medication history to identify potential external causes.

Treatment Protocols: Management strategies generally focus on removing or avoiding identified external agents. Supportive care, such as blood transfusions and antibiotics, helps manage symptoms and prevent complications. Immunosuppressive therapy is often employed if removal of external triggers does not suffice. Severe cases may require hematopoietic stem cell transplantation to restore normal blood cell production. Close medical supervision is crucial to address the risks associated with this condition effectively.